Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1740828
rs1740828 		G 0.710 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs1740828
rs1740828 		0.710 GeneticVariation GWASCAT We describe one new locus reaching genome-wide significance (P < 5 × 10 <sup>-</sup><sup>8</sup>) at 6p22.3 (rs1740828; P = 2.29 × 10 <sup>-</sup><sup>8</sup>, OR = 1.20), providing evidence of an additional region of interest for genetic susceptibility to endometrial cancer. 27008869

2016
dbSNP: rs1740828
rs1740828 		0.710 GeneticVariation BEFREE We describe one new locus reaching genome-wide significance (P < 5 × 10 <sup>-</sup><sup>8</sup>) at 6p22.3 (rs1740828; P = 2.29 × 10 <sup>-</sup><sup>8</sup>, OR = 1.20), providing evidence of an additional region of interest for genetic susceptibility to endometrial cancer. 27008869

2016
dbSNP: rs10835920
rs10835920 		T 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs113998067
rs113998067 		C 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs11583244
rs11583244 		T 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs117280150
rs117280150 		G 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs11841589
rs11841589 		G 0.700 GeneticVariation GWASCAT Five endometrial cancer risk loci identified through genome-wide association analysis. 27135401

2016
dbSNP: rs148261157
rs148261157 		A 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs1679014
rs1679014 		T 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs370989584
rs370989584 		CT 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs376674848
rs376674848 		CGT 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs4052756
rs4052756 		T 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs4733613
rs4733613 		C 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs4733613
rs4733613 		C 0.700 GeneticVariation GWASCAT Five endometrial cancer risk loci identified through genome-wide association analysis. 27135401

2016
dbSNP: rs571866661
rs571866661 		C 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs7981863
rs7981863 		C 0.700 GeneticVariation GWASCAT Identification of nine new susceptibility loci for endometrial cancer. 30093612

2018
dbSNP: rs9600103
rs9600103 		0.700 GeneticVariation GWASCAT GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer. 27008869

2016
dbSNP: rs12970291
rs12970291 		0.010 GeneticVariation BEFREE Another polymorphism, rs12970291 near gene TSHZ1, was associated with both CRC and EC (OR = 1.26, P = 4.82 × 10(-8)), with the alleles showing opposite effects on the risks of the two cancers. 26621817

2015
dbSNP: rs17782313
rs17782313 		0.010 GeneticVariation BEFREE The MC4R rs17782313 polymorphism was not related to endometrial cancer risk (per allele OR = 0.98; 95% CI: 0.91-1.06; p = 0.68). 21347432

2011
dbSNP: rs2046210
rs2046210 		0.010 GeneticVariation BEFREE Our study suggests that rs2046210 may play a role in the etiology of endometrial cancer. 21272446

2011
dbSNP: rs605965
rs605965 		0.010 GeneticVariation BEFREE The 870 G>A polymorphisms (rs605965) in the cyclin D1 gene was genotyped in an Australian endometrial cancer case-control population including 191 cases and 291 controls using real-time PCR analysis. 18822177

2008
dbSNP: rs7679673
rs7679673 		0.010 GeneticVariation BEFREE SNP rs7679673, ~6.3kb upstream of TET2 and previously reported to be associated with prostate cancer risk, was associated with endometrial cancer risk in the direction opposite to that for prostate cancer [meta-analysis odds ratio = 0.87 (per copy of the C allele), 95% confidence interval = 0.81, 0.93; P = 7.37×10(-5)] with no evidence of heterogeneity across studies (P heterogeneity = 0.66). 24832084

2014
dbSNP: rs8176323
rs8176323 		0.010 GeneticVariation BEFREE For BRCA1, the minor allele homozygotes of rs8067269 could decrease the risk of endometrial carcinoma (in co-dominant models: aOR = 0.52, 95% CI = 0.34-0.80, P = 0.0032), so was the haplotype CTCAG (rs8176323 + rs8176199 + rs3737559 + rs8067269 + rs2070833) (aOR = 0.69, 95% CI = 0.50-0.95, P = 0.0234). 25463638

2015
dbSNP: rs889312
rs889312 		0.010 GeneticVariation BEFREE We also observed a nonsignificant inverse association with rs889312 (MAP3K1) variant carriers [OR = 0.85 (95% CI: 0.68-1.05)] and rs1219648 (FGFR2) variant carriers [OR= 0.86 (95% CI: 0.69-1.06) and endometrial cancer risk. 18785201

2008